A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations

Neurology

Volumn 65, Issue 5, 2005, Pages 741-744

  Zabetian, C P ^a,b,e   Samii, A ^a,b   Mosley, A D ^d   Roberts, J W ^c   Leis, B C ^d   Yearout, D ^a,b   Raskind, W H ^a,b   Griffith, A ^d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VIRGINIA MASON MEDICAL CENTER   (United States)

^d Evergreen Hospital Medical Center   (United States)

^e VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EXON; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; LRRK2 GENE; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; RNA SPLICING;

EID: 24644486896     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000172630.22804.73     Document Type: Article

References (10)

1. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARKS-linked Parkinson's disease. Neuron 2004; 44:595-600.
2. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-607.
3. Bonifati V, Oostra BA, Heutink P. Unraveling the pathogenesis of Parkinson's disease-the contribution of monogenic forms. Cell Mol Life Sci 2004;61:1729-1750.
4. Kachergus J, Mata IF, Hulihan M, et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 2005;76:672-680.
5. Di Fonzo A, Rohe CF, Ferreira J, et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 2005;365:412-415.
6. Nichols WC, Pankratz N, Hernandez D, et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 2005;365:410-412.
7. Gilks WP, Abou-Sleiman PM, Gandhi S, et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005;365:415-416.
8. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32(suppl):S125-S127.
9. Bosgraaf L, Van Haastert PJ. Roc, a Ras/GTPase domain in complex proteins. Biochim Biophys Acta 2003;1643:5-10.
10. Brice A. How much does dardarin contribute to Parkinson's disease? Lancet 2005;365:363-364.